Jim Cramer Says 'There's Too Much Political Risk' For This Stock Is Up 106% In 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Rocket Pharmaceuticals Inc (NASDAQ: RCKT) is a "very early stage company that has a lot in the pipe. I tend to like these companies."

Analysts agree, Bezinga's Analyst Ratings data shows a consensus Buy rating, with all 10 analysts bullish on RCKT.

When asked about Sociedad Quimica y Minera de Chile SA (NYSE: SQM), he said, "I think there’s too much political risk." Analysts, however, have a consensus Buy rating on SQM.

Plug Power Inc (NASDAQ: PLUG) is "losing a fortune," he said. "They must get expenses under control."

Cramer said Anavex Life Sciences Corp (NASDAQ: AVXL) is "another one that I kind of like, I’ve got to tell you." However, he added, "I do not like losses in tech, but in biotech I can accept the fact that they have a good pipeline."

Also Read: Tesla Could Drop To $150 Before Year-End — Analyst Smells 'Window Of Opportunity' For Investors

When asked about GoPro Inc (NASDAQ: GPRO), Cramer said, "I just don’t think that they’re doing well enough to recommend."

Cramer said Illinois Tool Works Inc (NYSE: ITW) is the "kind of stock that is doing incredibly well."

When asked about Ryan Specialty Holdings Inc (NYSE: RYAN), he said, "I’ve got to find out what the hell went wrong with that one last week. " He added, "It’s usually a very normal, kind of regular company, and it got slammed."

Cramer said Shockwave Medical Inc (NASDAQ: SWAV) is a "good company, very expensive stock, though."

Photo: Courtesy of Owen Byrne on flickr